AlzeCure’s ACD856’s effects to be presented at Alzheimer’s conference
2nd October 2024 Uncategorised 0
Preclinical data on NeuroRestore therapy to be showcased at CTAD in Madrid

More: AlzeCure’s ACD856’s effects to be presented at Alzheimer’s conference
Source: News
